Try Magic Notes and save time.Try it free
Try Magic Notes and save timeCrush your year with the magic of personalized studying.Try it free

Related questions with answers

W.V. is a 5757-year-old man who lives with his wife and two teenage sons. W.V. developed chronic kidney disease 2020 years ago after he developed acute kidney disease from using a drug for migraine headaches that was later shown to cause severe nephrotoxicity. W.V. underwent hemodialysis for 55 years before receiving a cadaveric transplant, or cadaver kidney. He recovered without complications, and his serum laboratory values returned to normal. He was placed on triple immunosuppression therapy, including prednisone (Deltasone), cyclosporine (Imuran), and tacrolimus (Prograf), and was discharged to home.

Today, W.V. reports to his physician for a 1212-week follow-up. He returned to work 33 weeks ago. W.V. has gained 55 pounds since his last appointment 22 weeks ago.

 Vital Signs  Blood pressure 148/82 mmHg Pulse rate 88 beats /min Respiratory rate 24 breaths /min Temperature 99.2F(37.3C)\begin{aligned} &\text { Vital Signs }\\ &\begin{array}{ll} \text { Blood pressure } & 148 / 82 \mathrm{~mm} \mathrm{Hg} \\ \text { Pulse rate } & 88 \text { beats } / \mathrm{min} \\ \text { Respiratory rate } & 24 \text { breaths } / \mathrm{min} \\ \text { Temperature } & 99.2^{\circ} \mathrm{F}\left(37.3^{\circ} \mathrm{C}\right) \end{array} \end{aligned}

 Laboratory Test Results  Creatinine 1.2mg/dL BUN 22mg/dL\begin{aligned} &\text { Laboratory Test Results }\\ &\begin{array}{ll} \text { Creatinine } & 1.2 \mathrm{mg} / \mathrm{dL} \\ \text { BUN } & 22 \mathrm{mg} / \mathrm{dL} \end{array} \end{aligned}

The physician decides to add mycophenolate (CellCept) 11 g twice daily to W.V.'s immunosuppressive regimen. How does mycophenolate (CellCept) protect W.V.'s kidney from rejection, and what points should you include in a teaching plan for W.V.?

Question

What do you need to teach W.V. regarding therapy with mycophenolate?

Solution

Verified
Step 1
1 of 2

Mycophenolate even though it is successful in decreasing the chance of graft rejection it still has its limitations. Several studies showed that hematologic abnormalities and gastrointestinal intolerance may occur commonly with patients recommended with MMF. One example is the presence of leukopenia in renal transplant patients taking Mycophenolate.A person who is taking this drug should avoid sunlight and must wear protective clothing and hats between 10 am-3 pm. Do note that this drug lowers the number of WBC which increases the chance of the patient to be infected.

Mycophenolate can be taken orally and IV and used along with cyclosporine and corticosteroids. For kidney transplant patients, it is administered by 1 g PO/IV q12hr, infused over \geq 2 hours

Create an account to view solutions

Create an account to view solutions

Recommended textbook solutions

Pharmacology and the Nursing Process 7th Edition by Julie S Snyder, Linda Lilley, Shelly Collins

Pharmacology and the Nursing Process

7th EditionISBN: 9780323087896Julie S Snyder, Linda Lilley, Shelly Collins
397 solutions
Winningham's Critical Thinking Cases in Nursing 6th Edition by Julie S Snyder, Mariann M Harding

Winningham's Critical Thinking Cases in Nursing

6th EditionISBN: 9780323291965 (1 more)Julie S Snyder, Mariann M Harding
2,214 solutions
The Human Body in Health and Disease 7th Edition by Gary A. Thibodeau, Kevin T. Patton

The Human Body in Health and Disease

7th EditionISBN: 9780323402118 (5 more)Gary A. Thibodeau, Kevin T. Patton
1,525 solutions
Clinical Reasoning Cases in Nursing 7th Edition by Julie S Snyder, Mariann M Harding

Clinical Reasoning Cases in Nursing

7th EditionISBN: 9780323527361Julie S Snyder, Mariann M Harding
2,565 solutions

More related questions

1/4

1/7